Transgenic mouse models of sickle cell disease

Current Opinion in Hematology

Volumn 3, Issue 2, 1996, Pages 150-155

  Beuzard, Yves ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISICKLING AGENT; BETA GLOBIN; CLOTRIMAZOLE; GAMMA GLOBIN; HEMOGLOBIN F; HEMOGLOBIN S; MAGNESIUM ION; VELARESOL;

ANIMAL MODEL; CELL HYPOXIA; CONTROLLED STUDY; FETUS; GENE TARGETING; GLOBIN GENE; HEMATOCRIT; HEMOGLOBIN SYNTHESIS; HEMOLYSIS; HOMOZYGOSITY; INFARCTION; INTRAPERITONEAL DRUG ADMINISTRATION; MICROTHROMBUS; MOUSE; NEWBORN; NONHUMAN; ORAL DRUG ADMINISTRATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PHENOTYPE; PRIAPISM; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; TRANSGENIC ANIMAL; YEAST ARTIFICIAL CHROMOSOME;

EID: 0029895736     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199603020-00008     Document Type: Review

References (30)

1. Magram J, Chada K, Costantini F: Developmental regulation of a cloned adult β-globin gene in transgenic mice. Nature 1985, 315:338-340.
2. Smithies O: Animal models of human genetic diseases. Trends Genet 1993, 9:112-117.
3. Costantini F, Chada K, Magram J: Correction of murine β-thalassemia by gene transfer into the germ line. Science 1986, 233:1192-1194.
4. s Antilles chains. Biochim Biophys Acta 1988, 952:208-212.
5. s chain-dependent polymerization by Mouse α-chain. J Biol Chem 1993, 268:16406-16412.
6. Grosveld F, van Assendelft GB, Greaves DR, Kollias G: Position-independent, high-level expression of the human β-globin gene in transgenic mice. Cell 1987, 51:975-985.
7. Behringer RR, Ryan TM, Reilly MP, Asakura T, Palmiter RD, Brinster RL, Townes TM: Synthesis of functional human hemoglobin in transgenic mice. Science 1989, 245:971-973.
8. Greaves RG, Fraser P, Vidal MA, Hedges MJ, Roper D, Luzzatto L, Grosveld F: A transgenic mouse model for sickle cell disorder. Nature 1990, 343:183-185.
9. Ryan TM, Townes TM, Reilly MP, Asakura T, Palmiter RD, Brinster RL, Behringer RR: Human sickle hemoglobin in transgenic mice. Science 1990, 247:566-568.
10. s- and α-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci U S A 1992, 89:12150-12154.
11. 5- and α-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci U S A 1992, 89:12155-12159.
12. Monplaisir N, Merault G, Poyart C, Rhoda MD, Craescu C, Vidaud M, Galacteros F, Blouquit Y, Rosa J: Hemoglobin S Antilles: a variant with lower solubility than hemoglobin S and producing sickle cell disease in heterozygotes. Proc Natl Acad Sci U S A 1986, 83:9363-9367.
13. Rubin EM, Witkowska HE, Spangler E, Curtin P, Lubin BH, Mohandas N, Clift SM: Hypoxia-induced in vivo sickling of transgenic mouse red cells. J Clin Invest 1991, 87:639-647.
14. Fabry ME, Sengupta A, Suzuka SM, Costantini F, Rubin EM, Hofrichter J, Christophe G, Manci E, Culberson D, Factor SM, Nagel RL: A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity. Blood 1995, 86:2419-2428. Complex genotype inducing a moderate sickle cell syndrome in mice.
15. Trudel M, Saadane N, Garel MC, Bardakdjian-Michau J, Blouquit Y, Guerquin-Kern JL, Rouyer-Fessard P, Vidaud D, Pachnis A, Roméo PH, Beuzard Y, Costantini F: Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. EMBO J 1991, 10:3157-3167.
16. Trudel M, De Paepe M, Saadane N, Chrétien N, Beuzard Y: The sickle cell disease of transgenic SAD mice. Blood 1994, 84:3189-3197. Mouse model with a super hemoglobin S inducing the most severe sickle cell syndrome in mice.
17. + transport and reverses erythrocytes dehydration in transgenic SAD mice: a model for therapy of sickle cell disease. J Clin Invest 1994, 93:1670-1676. First efficient therapy in transgenic mice.
18. de Franceschi L, Rouyer-Fessard P, Alper SL, Joualut H, Brugnara C, Beuzard Y: Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a β thalassemic mouse: a model for human therapy. Blood 1996, In press.
19. Brugnara C: Erythrocyte dehydration in pathophysiology and treatment of sickle cell disease. Curr Opin Hematol 1995, 2:132-138.
20. de Paepe ME, Trudel M: The transgenic SAD mouse: a model of human sickle cell glomerulopathy. Kidney Int 1994, 46:1337-1345.
21. Falk RJ, Scheinman J, Phillips G, Orringer E, Johnson A, Jennette JC: Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme. N Engl J Med 1992, 326:910-915.
22. Asakura T, Mattiello JA, Obata K, Asakura K, Reilly MP, Tomassini N, Schwartz E, Ohene-Frempong K: Partially oxygenated sickled cells: sickle-shaped red cells found in circulating blood of patients with sickle cell disease. Proc Natl Acad Sci U S A 1994, 81:12589-12593.
23. Brugnara C, Gee B, Armsby C, Kurth S, Sakamoto M, Rifai N, Alper SL, Platt O: Inhibition of Gardos channel and red cell dehydration by oral administration of clotrimazole in sickle cell disease [abstract]. Blood 1994, 84:220a.
24. de Franceschi L, Brugnara C, Beuzard Y: Magnesium intake affects K-Cl cotransport and cell dehydration in transgenic SAD mice: a model for sickle cell disease therapy [abstract]. Blood 1996, 86:199.
25. s-globin gene by gene targeting. Proc Natl Acad Sci U S A 1991, 88:4294-4298.
26. Shehee WR, Oliver P, Smithies O: Lethal thalassemia after insertional disruption of the mouse major adult β-globin gene. Proc Natl Acad Sci U S A 1993, 90:3177-3181.
27. mln- globin genes in embryonic stem cells. Proc Natl Acad Sci U S A 1995, 92:9259-9263.
28. Paszty C, Mohandas N, Stevens ME, Loring JF, Liebhaber SA, Brion CM, Rubin EM: Lethal α-thalassaemia created by gene targeting in mice and its genetic rescue. Nature Gen 1995, 11:33-39.
29. Peterson KR, Clegg CH, Huxley C, Josephson BM, Haugen HS, Furukawa T, Stamatoyannopoulos G: Transgenic mice containing a 248-kb yeast artificial chromosome carrying the human β-globin locus display proper developmental control of human globin genes. Proc Natl Acad Sci U S A 1993, 90:7593-7597.
30. s YAC and the modulation of γ genes in CIS.